FDA approves overdose-reversing Narcan for sale without prescription

Move seen as a key strategy to control the US overdose crisis, which has been linked to more than 100,000 deaths a year

The US Food and Drug Administration on Wednesday approved selling naloxone without a prescription, setting the overdose-reversing drug on course to become the first opioid treatment drug to be sold over counters in the US.

It is a move some advocates have long sought as a way to improve access to a life-saving drug, though the exact impact will not be clear immediately.